IP Library Granted Patent US 7,702,598
Granted Patent B2
US 7,702,598 · App. 12/009,543 · Granted Apr 20, 2010

Methods and systems for predicting occurrence of an event

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,702,598
App. No.
12/009,543
Granted
Apr 20, 2010
Kind
B2
Abstract

Embodiments of the present invention are directed to methods and systems for training a neural network having weighted connections for classification of data, as well as embodiments corresponding to the use of such a neural network for the classification of data, including, for example, prediction of an event (e.g., disease). The method may include inputting input training data into the neural network, processing, by the neural network, the input training data to produce an output, determining an error between the output and a desired output corresponding to the input training data, rating the performance neural network using an objective function, wherein the objective function comprises a function C substantially in accordance with an approximation of the concordance index and adapting the weighted connections of the neural network based upon results of the objective function.

Claims (571)

1. Apparatus for predicting occurrence of a medical condition in a patient under consideration comprising:

a neural network having weighted connections, an input and an output, said weighted connections resulting from training said neural network;

wherein said input is configured to receive data for said patient under consideration and, based on said weighted connections, said neural network is configured to provide at said output a prognostic indicator of the risk of occurrence of the medical condition in said patient; and

wherein said neural network is trained with an objective function C for providing a rating of the performance of the neural network, wherein the objective function C is a differentiable approximation of the concordance index, said training of said neural network with the objective function C comprising conducting pair-wise comparisons between prognostic indicators from said neural network of pairs of patients i and j from a training dataset comprising both censored and non-censored data and adapting said weighted connections of said neural network as a result of said comparisons, said pairs of patients from said training dataset comprising:

patients i and j who have both experienced the medical condition, and the time t i to occurrence of the medical condition of patient i is shorter than the time t j to occurrence of the medical condition of patient j; and

patients i and j where only patient i has experienced the medical condition, and the time t i to occurrence of the medical condition in patient i is shorter than a follow-up visit time t j for patient j.

2. The apparatus according to claim 1 , wherein said neural network is configured to receive at said input data for said patient under consideration comprising clinical data, molecular biomarker data, and histopathological data resulting from machine vision analysis of tissue, and based on said weighted connections, to provide at said output said prognostic indicator for said patient.

3. The apparatus according to claim 1 , wherein said medical condition comprises recurrence of prostate cancer and said prognostic indicator indicates a likelihood of recurrence of prostate cancer in said patient under consideration within a certain amount of time.

4. The apparatus according to claim 1 , wherein the function C is defined according to

C

=

(

i

,

j

)

Ω

R

(

t

^

i

,

t

^

j

)

|

Ω

|

,

wherein Ω comprises said pairs of patients (i, j), wherein R is defined according to

R

(

t

^

i

,

t

^

j

)

=

{

(

-

(

t

^

i

-

t

^

j

-

γ

)

)

n

:

t

^

i

-

t

^

j

<

γ

0

:

otherwise

}

,

wherein {circumflex over (t)} i and {circumflex over (t)} j include prognostic estimates for patients i and j, respectively, and wherein 0<γ<1 and n>1.

5. The apparatus according to claim 1 , wherein the function C is defined according to

C

ω

=

(

i

,

j

)

Ω

-

(

t

^

i

-

t

^

j

)

·

R

(

t

^

i

,

t

^

j

)

D

,

wherein

D

=

(

i

,

j

)

Ω

-

(

t

^

i

-

t

^

j

)

is a normalization factor, and Ω comprises said pairs of patients (i, j), wherein R is defined according to

R

(

t

^

i

,

t

^

j

)

=

{

(

-

t

^

i

-

t

^

j

-

γ

)

)

n

:

t

^

i

-

t

^

j

<

γ

0

:

otherwise

}

,

wherein {circumflex over (t)} i and {circumflex over (t)} j include prognostic estimates for patients i and j, respectively, and wherein 0<γ<1 and n>1.

6. The apparatus according to claim 1 , wherein said medical condition comprises recurrence of prostate cancer and said prognostic indicator indicates an amount of time in which recurrence of prostate cancer in said patient under consideration is likely to occur.

7. A method for predicting occurrence of a medical condition in a patient under consideration:

inputting data into a neural network having weighted connections in order to produce an output, said weighted connections resulting from training said neural network;

wherein said inputting data comprises inputting data for said patient under consideration and said output comprises a prognostic indicator indicative of the risk of occurrence of the medical condition in said patient; and

wherein said training said neural network comprises training said neural network with an objective function C that provides a rating of the performance of the neural network, wherein the objective function C is a differentiable approximation of the concordance index, said training of said neural network with the objective function C comprising conducting pair-wise comparisons between prognostic indicators from said neural network of pairs of patients i and j from a training dataset comprising both censored and non-censored data and adapting said weighted connections of said neural network as a result of said comparisons, said pairs of patients from said training dataset comprising:

patients i and j who have both experienced the medical condition and the time t i to occurrence of the medical condition of patient i is shorter than the time t j to occurrence of the medical condition of patient j; and

patients i and j where only patient i has experienced the medical condition and the time t j to occurrence of the medical condition in patient i is shorter than a follow-up visit time t j for patient j.

8. The method according to claim 7 , wherein said inputting data for said patient under consideration comprises inputting data for said patient comprising clinical data, molecular biomarker data, and histopathological data resulting from machine vision analysis of tissue, and based on said weighted connections, outputting said prognostic indicator for said patient.

9. The method according to claim 7 , wherein said medical condition comprises recurrence of prostate cancer and the prognostic indicator is indicative of a likelihood of recurrence of prostate cancer in said patient under consideration within a certain amount of time.

10. The method according to claim 7 , wherein the function C is defined according to

C

=

(

i

,

j

)

Ω

R

(

t

^

i

,

t

^

j

)

|

Ω

|

,

and wherein Ω comprises said pairs of patients (i, j) wherein R is defined according to

R

(

t

^

i

,

t

^

j

)

=

{

(

-

(

t

^

i

-

t

^

j

-

γ

)

)

n

:

t

^

i

-

t

^

j

<

γ

0

:

otherwise

}

,

wherein {circumflex over (t)} i and {circumflex over (t)} j include prognostic estimates for patients i and j, respectively, and wherein 0<γ<1 and n>1.

11. The method according to claim 7 , wherein the function C is defined according to:

C

ω

=

(

i

,

j

)

Ω

-

(

t

^

i

-

t

^

j

)

·

R

(

t

i

^

,

t

^

j

)

D

,

wherein

D

=

(

i

,

j

)

Ω

-

(

t

^

i

-

t

^

j

)

is a normalization factor, and wherein Ω comprises said pairs of patients (i, j), wherein R is defined according to

R

(

t

^

i

,

t

^

j

)

=

{

(

-

(

t

^

i

-

t

^

j

-

γ

)

)

n

:

t

^

i

-

t

^

j

<

γ

0

:

otherwise

}

,

wherein {circumflex over (t)} i and {circumflex over (t)} j include prognostic estimates for patients i and j, respectively, and wherein 0<γ<1 and n>1.

12. The method according to claim 7 , wherein said medical condition comprises recurrence of prostate cancer and outputting said prognostic indicator comprises outputting a prognostic indicator indicative of an amount of time in which recurrence of prostate cancer in said patient under consideration is likely to occur.

13. Computer readable media comprising computer instructions for causing a computer to perform the method comprising:

inputting data into a neural network having weighted connections in order to produce an output, said weighted connections resulting from training said neural network;

wherein said inputting data comprises inputting data for said patient under consideration and said output comprises a prognostic indicator indicative of the risk of occurrence of the medical condition in said patient; and

wherein said training said neural network comprises training said neural network with an objective function C that provides a rating of the performance of the neural network, wherein the objective function C is an differentiable approximation of the concordance index, said training of said neural network with the objective function C comprising conducting pair-wise comparisons between prognostic indicators from said neural network of pairs of patients i and j from a training dataset comprising both censored and non-censored data and adapting said weighted connections of said neural network as a result of said comparisons, said pairs of patients from said training dataset comprising:

patients i and j who have both experienced the medical condition and the time t i to occurrence of the medical condition of patient i is shorter than the time t j to occurrence of the medical condition of patient j; and

patients i and j where only patient i has experienced the medical condition and the time t i to occurrence of the medical condition in patient i is shorter than a follow-up visit time t j for patient j.

14. The computer readable media according to claim 13 , wherein said inputting data for said patient under consideration comprises inputting data for said patient comprising clinical data, molecular biomarker data, and histopathological data resulting from machine vision analysis of tissue, and based on said weighted connections, outputting said prognostic indicator for said patient.

15. The computer readable media according to claim 13 , wherein said medical condition comprises recurrence of prostate cancer and outputting said prognostic indicator comprises outputting a prognostic indicator indicative of a likelihood of recurrence of prostate cancer in said patient under consideration within a certain amount of time.

16. The computer readable media according to claim 13 , wherein the function C is defined according to

C

=

(

i

,

j

)

Ω

R

(

t

^

i

,

t

^

j

)

|

Ω

|

,

and wherein Ω comprises said pairs of patients (i, j), wherein R is defined according to

R

(

t

^

i

,

t

^

j

)

=

{

(

-

(

t

^

i

-

t

^

j

-

γ

)

)

n

:

t

^

i

-

t

^

j

<

γ

0

:

otherwise

}

,

wherein {circumflex over (t)} i and {circumflex over (t)} j include prognostic estimates for the patients i and j, respectively, and wherein 0<γ<1 and n>1.

17. The computer readable media according to claim 13 , wherein the function C is defined according to:

C

ω

=

(

i

,

j

)

Ω

-

(

t

^

i

-

t

^

j

)

·

R

(

t

i

^

,

t

^

j

)

D

,

wherein

D

=

(

i

,

j

)

Ω

-

(

t

^

i

-

t

^

j

)

is a normalization factor, and wherein Ω comprises said pairs of patients (i, j), wherein R is defined according to

R

(

t

^

i

,

t

^

j

)

=

{

(

-

(

t

^

i

-

t

^

j

-

γ

)

)

n

:

t

^

i

-

t

^

j

<

γ

0

:

otherwise

}

,

wherein {circumflex over (t)} i and {circumflex over (t)} j include prognostic estimates for the patients i and j, respectively, and wherein 0<γ<1 and n>1.

18. The computer readable media according to claim 13 , wherein said medical condition comprises recurrence of prostate cancer and outputting said prognostic indicator comprises outputting a prognostic indicator indicative of an amount of time in which recurrence of prostate cancer in said patient under consideration is likely to occur.

Assignments (8)
THIS IS TO CORRECT ERRORS IN A COVER SHEET PREVIOUSLY RECORDED (REEL/FRAME 027502/0828): CORRECTION OF THE ASSIGNOR'S NAME TO AUREON (ASSIGNMENT FOR THE BENEFIT OF CREDITORS), LLC.; CORRECTION OF THE ASSIGNEE'S NAME TO AUREON, INC. Recorded May 22, 2012
From: AUREON (ASSIGNMENT FOR THE BENEFIT OF CREDITORS), LLC
To: AUREON, INC.
Reel/Frame 028252/0442 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded May 21, 2012
From: AUREON, INC.
To: CHAMPALIMAUD FOUNDATION
Reel/Frame 028244/0077 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jan 9, 2012
From: AUREON BIOSCIENCES, INC.
To: DAVID SANS
Reel/Frame 027502/0828 →
SECURITY AGREEMENT Recorded Oct 25, 2010
From: AUREON BIOSCIENCES, INC.
To: ATLAS VENTURE FUND VI GMBH & CO. KG; ATLAS VENTURE FUND VI, L.P.; ATLAS VENTURE ENTREPRENEURS' FUND VI, L.P.; PFIZER INC.; MINTZ LEVIN INVESTMENTS LLC; SPROUT CAPITAL IX, L.P.; DLJ CAPITAL CORP.; SPROUT ENTREPRENEURS FUND, L.P.; SPROUT IX PLAN INVESTORS, L.P.; CANTABRIA DE ACTIVOS, S.L.; CORPORACION MASAVEU, S.A.; INICIATIVAS DIGITALES; IPETEX S.A.; INVERSIONES VECU 2006, S.L.; LEALTAD DESARROLLO, S.C.R., S.A.; BASSETTI, MARCO; C+PA-CIMENTO E PRODUTOS ASSOCIADOS, S.A.
Reel/Frame 025178/0899 →
SECURITY AGREEMENT Recorded Aug 9, 2010
From: AUREON BIOSCIENCES, INC.
To: ATLAS VENTURE FUND VI, L.P.; ATLAS VENTURE FUND VI GMBH & CO. KG; ATLAS VENTURE ENTREPRENEURS' FUND VI, L.P.; SPROUT ENTREPRENEURS FUND, L.P.; SPROUT CAPITAL IX, L.P.; DLJ CAPITAL CORP.; SPROUT IX PLAN INVESTORS, L.P.; PFIZER INC; MINTZ LEVIN INVESTMENTS LLC; INICIATIVAS DIGITALES; INVERSIONES VECU 2006, S.L.; LEALTAD DESARROLLO, S.C.R., S.A.; IPETEX S.A.; CANTABRIA DE ACTIVOS, S.L.; CORPORACION MASAVEU, S.A.; PEREZ DE ARMINAN, ALFREDO; FERNANDEZ DE VILLAVICENCIO, GABRIEL STAMOGLOU; FERNANDEZ DE VILLAVICENCIO, ALEJANDRO STAMOGLOU
Reel/Frame 024946/0493 →
SECURITY AGREEMENT Recorded Jan 12, 2010
From: AUREON LABORATORIES, INC.
To: ATLAS VENTURE ENTREPRENEURS' FUND VI, L.P.; ATLAS VENTURE FUND VI GMBH & CO. KG; ATLAS VENTURE FUND VI, L.P.; SPROUT CAPITAL IX, L.P.; DLJ CAPITAL CORP.; SPROUT IX PLAN INVESTORS, L.P.; SPROUT ENTREPRENEURS' FUND, L.P.; PFIZER INC.; CANTABRIA DE ACTIVOS, S.L.; CORPORACION MASAVEU, S.A.; LEALTAD DESARROLLO, S.C.R., S.A.; INICIATIVAS DIGITALES; INVERSIONES VECU 2006, S.L.; MARCO BASSETTI; ESTRELA - SGPS, S.A.; MINTZ LEVIN INVESTMENTS LLC
Reel/Frame 023768/0486 →
CHANGE OF NAME Recorded Jan 7, 2010
From: AUREON BIOSCIENCES CORPORATION
To: AUREON LABORATORIES, INC.
Reel/Frame 023748/0257 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jan 7, 2010
From: SAIDI, OLIVIER; VERBEL, DAVID A.; YAN, LIAN
To: AUREON BIOSCIENCES CORPORATION
Reel/Frame 023748/0197 →